FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000281728> ?p ?o ?g. }

• W2000281728 endingPage "1431" @default.
• W2000281728 startingPage "1426" @default.
• W2000281728 abstract "Chronic hepatitis C is a common cause of viral liver disease in kidney transplant (KT) recipients. To assess the efficacy and safety of therapy with interferon alpha we conducted a prospective study where 14 cadaveric KT recipients with chronic hepatitis C received recombinant interferon alpha-2b (IFNa) 3 million units three times weekly (scheduled) for 6 months (group A). 14 KT recipients with chronic hepatitis C were not treated and served as controls for the study period (group B). All the patients in both groups had had stable renal function for at least one year. All patients in both groups had a positive HCV viremia at the beginning of the study. Patients of group A were treated for 142 +/- 34.8 days (range 65-168); elevated serum aminotransferase (ALT) levels decreased rapidly and significantly from 100.3 +/- 48.9 to 37.7 +/- 13.9 IU/L (P = 0.001); 10 patients (77%) were responders, whereas the others experienced a decrease in ALT values but without reaching the normal ranges. With a mean follow-up of twelve months after discontinuation of IFNa therapy, 8 responders--i.e., 80%--relapsed within 1-20 weeks. Only 4 patients had no detectable HCV viremia at the end of the IFNa; two of them already have abnormal values of ALT. Moreover HCV viremia was present in all patients one month after the cessation of IFNa treatment. Side effects of IFNa (fatigue, anorexia, weight loss) were frequent, and 3 patients decided to drop out of the treatment. The hematological tolerance was good although there was a significant decrease in hemoglobin (11.9 +/- 1.7 vs. 13.4 +/- 1.7 g/dl; P = 0.0044). In group B, serum ALT levels did not significantly decrease (84.2 +/- 47.6 vs. 105.2 +/- 68.8 IU/L). At the end of the study period serum ALT levels were significantly lower in group A than in group B (37.7 +/- 13.9 vs. 84.2 +/- 47.6 IU/L, P = 0.013). The major concern in group A was the occurrence of 5 renal failures. Kidney transplant biopsies showed edema, no significant tubulitis, scarcely scattered interstitial inflammatory cellular infiltration, and mesangial thickening. Four patients received methylprednisolone pulses but renal function improved in only two cases. We were not able to discover predictive factors of renal failure. We conclude that IFNa therapy is effective in controlling disease activity--i.e., reducing amino-transferase levels in KT patients with chronic hepatitis C, although relapse and detection of HCV RNA after the cessation of treatment were observed, respectively, in 80% and 100% of patients.(ABSTRACT TRUNCATED AT 400 WORDS)" @default.
• W2000281728 created "2016-06-24" @default.
• W2000281728 creator A5004626211 @default.
• W2000281728 creator A5010530258 @default.
• W2000281728 creator A5037176928 @default.
• W2000281728 creator A5066608092 @default.
• W2000281728 creator A5080763997 @default.
• W2000281728 creator A5082049706 @default.
• W2000281728 date "1995-05-01" @default.
• W2000281728 modified "2023-09-27" @default.
• W2000281728 title "TREATMENT OF CHRONIC HEPATITIS C WITH RECOMBINANT INTERFERON ALPHA IN KIDNEY TRANSPLANT RECIPIENTS" @default.
• W2000281728 doi "https://doi.org/10.1097/00007890-199505270-00012" @default.
• W2000281728 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7770930" @default.
• W2000281728 hasPublicationYear "1995" @default.
• W2000281728 type Work @default.
• W2000281728 sameAs 2000281728 @default.
• W2000281728 citedByCount "183" @default.
• W2000281728 countsByYear W20002817282012 @default.
• W2000281728 countsByYear W20002817282013 @default.
• W2000281728 countsByYear W20002817282014 @default.
• W2000281728 countsByYear W20002817282015 @default.
• W2000281728 countsByYear W20002817282016 @default.
• W2000281728 countsByYear W20002817282017 @default.
• W2000281728 countsByYear W20002817282018 @default.
• W2000281728 countsByYear W20002817282019 @default.
• W2000281728 countsByYear W20002817282020 @default.
• W2000281728 countsByYear W20002817282021 @default.
• W2000281728 countsByYear W20002817282022 @default.
• W2000281728 crossrefType "journal-article" @default.
• W2000281728 hasAuthorship W2000281728A5004626211 @default.
• W2000281728 hasAuthorship W2000281728A5010530258 @default.
• W2000281728 hasAuthorship W2000281728A5037176928 @default.
• W2000281728 hasAuthorship W2000281728A5066608092 @default.
• W2000281728 hasAuthorship W2000281728A5080763997 @default.
• W2000281728 hasAuthorship W2000281728A5082049706 @default.
• W2000281728 hasBestOaLocation W20002817281 @default.
• W2000281728 hasConcept C126322002 @default.
• W2000281728 hasConcept C203014093 @default.
• W2000281728 hasConcept C2522874641 @default.
• W2000281728 hasConcept C2776029263 @default.
• W2000281728 hasConcept C2776178377 @default.
• W2000281728 hasConcept C2776185481 @default.
• W2000281728 hasConcept C2776455275 @default.
• W2000281728 hasConcept C2778715236 @default.
• W2000281728 hasConcept C2781228144 @default.
• W2000281728 hasConcept C2909179924 @default.
• W2000281728 hasConcept C71924100 @default.
• W2000281728 hasConcept C90924648 @default.
• W2000281728 hasConceptScore W2000281728C126322002 @default.
• W2000281728 hasConceptScore W2000281728C203014093 @default.
• W2000281728 hasConceptScore W2000281728C2522874641 @default.
• W2000281728 hasConceptScore W2000281728C2776029263 @default.
• W2000281728 hasConceptScore W2000281728C2776178377 @default.
• W2000281728 hasConceptScore W2000281728C2776185481 @default.
• W2000281728 hasConceptScore W2000281728C2776455275 @default.
• W2000281728 hasConceptScore W2000281728C2778715236 @default.
• W2000281728 hasConceptScore W2000281728C2781228144 @default.
• W2000281728 hasConceptScore W2000281728C2909179924 @default.
• W2000281728 hasConceptScore W2000281728C71924100 @default.
• W2000281728 hasConceptScore W2000281728C90924648 @default.
• W2000281728 hasIssue "10" @default.
• W2000281728 hasLocation W20002817281 @default.
• W2000281728 hasLocation W20002817282 @default.
• W2000281728 hasOpenAccess W2000281728 @default.
• W2000281728 hasPrimaryLocation W20002817281 @default.
• W2000281728 hasRelatedWork W1898974520 @default.
• W2000281728 hasRelatedWork W2059217612 @default.
• W2000281728 hasRelatedWork W2077589807 @default.
• W2000281728 hasRelatedWork W2098357894 @default.
• W2000281728 hasRelatedWork W2150102564 @default.
• W2000281728 hasRelatedWork W2229086442 @default.
• W2000281728 hasRelatedWork W2414652355 @default.
• W2000281728 hasRelatedWork W2419349742 @default.
• W2000281728 hasRelatedWork W2462498398 @default.
• W2000281728 hasRelatedWork W2471136790 @default.
• W2000281728 hasVolume "59" @default.
• W2000281728 isParatext "false" @default.
• W2000281728 isRetracted "false" @default.
• W2000281728 magId "2000281728" @default.
• W2000281728 workType "article" @default.